KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Other Operating Expenses (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Other Operating Expenses readings, the most recent being $821000.0 for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 21.73% to $821000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.5 million, a 216.98% decrease, with the full-year FY2025 number at -$4.5 million, down 216.98% from a year prior.
  • Other Operating Expenses hit $821000.0 in Q4 2025 for Ginkgo Bioworks Holdings, up from -$163000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $7.1 million in Q2 2021 to a low of -$4.9 million in Q3 2021.
  • Median Other Operating Expenses over the past 5 years was $525500.0 (2022), compared with a mean of $719100.0.
  • Biggest five-year swings in Other Operating Expenses: surged 1301.74% in 2023 and later plummeted 312.85% in 2025.
  • Ginkgo Bioworks Holdings' Other Operating Expenses stood at -$2.6 million in 2021, then surged by 337.33% to $6.2 million in 2022, then tumbled by 98.49% to $93000.0 in 2023, then skyrocketed by 1027.96% to $1.0 million in 2024, then decreased by 21.73% to $821000.0 in 2025.
  • The last three reported values for Other Operating Expenses were $821000.0 (Q4 2025), -$163000.0 (Q3 2025), and -$896000.0 (Q2 2025) per Business Quant data.